alendronate has been researched along with Hearing Loss in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 3-year, randomized, double-blind, placebo-controlled trial evaluated the effect of oral alendronate on the BMD of 64 adult patients with osteogenesis imperfecta." | 9.12 | Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. ( Arlot, M; Charrin, JE; Chevrel, G; Duboeuf, F; Fontanges, E; Garnero, P; Lina-Granade, G; Meunier, PJ; Raynal, C; Schott, AM, 2006) |
| "A 3-year, randomized, double-blind, placebo-controlled trial evaluated the effect of oral alendronate on the BMD of 64 adult patients with osteogenesis imperfecta." | 5.12 | Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. ( Arlot, M; Charrin, JE; Chevrel, G; Duboeuf, F; Fontanges, E; Garnero, P; Lina-Granade, G; Meunier, PJ; Raynal, C; Schott, AM, 2006) |
| "Otospongiosis is a primary osteodystrophy of the otic capsule that affects genetically predisposed individuals and leads to a progressive hearing loss." | 2.77 | The effectiveness of audiometric evaluation in drug treatment for otospongiosis. ( Cruz, OL; Penido, Nde O; Suzuki, FB; Vicente, Ade O; Yamashita, HK, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vicente, Ade O | 1 |
| Yamashita, HK | 1 |
| Cruz, OL | 1 |
| Suzuki, FB | 1 |
| Penido, Nde O | 1 |
| Chevrel, G | 1 |
| Schott, AM | 1 |
| Fontanges, E | 1 |
| Charrin, JE | 1 |
| Lina-Granade, G | 1 |
| Duboeuf, F | 1 |
| Garnero, P | 1 |
| Arlot, M | 1 |
| Raynal, C | 1 |
| Meunier, PJ | 1 |
2 trials available for alendronate and Hearing Loss
| Article | Year |
|---|---|
The effectiveness of audiometric evaluation in drug treatment for otospongiosis.
Topics: Adult; Aged; Alendronate; Audiometry; Auditory Threshold; Bone Conduction; Bone Density Conservation | 2012 |
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Alendronate; Biomarkers; Bone Density; Bone Den | 2006 |